Registered entities
CRISPR THERAPEUTICS, INC.
Reg. No. 473173478United States
Crispr Therapeutics Ag
Reg. No. 1674416United States
Innovation
164 patent families (49 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 35,099 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 13 |
| 2018 | 31 |
| 2019 | 39 |
| 2020 | 45 |
| 2021 | 52 |
| 2022 | 63 |
| 2023 | 68 |
| 2024 | 41 |
| 2025 | 43 |
| 2026 | 7 |
Social engagement
Social engagement: 111.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include Vertex Pharmaceuticals, Franklin Templeton Investments, New Leaf Venture Partners, Wellington; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 5 | 42% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
3 Mar 2026 · Senior Manager, Supply Chain · Boston
19 Nov 2025 · Senior Manager/Associate Director, Business Development · Boston
17 Jun 2025 · Medical Writer/Senior Medical Writer · Boston
Based on job postings tracked across public sources.
Recent activity
4 May 2026
Milestone
revenue
20 Apr 2026
Recognition
12 Feb 2026
Milestone
revenue